[
  {
    "ts": null,
    "headline": "Scotiabank Analyst Sees Opportunity in Large Cap Biopharma, Keeps Outperform on GILD",
    "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) is included among the 15 Best Passive Income Stocks to Buy Right Now. On November 12, Scotiabank an⁠aly​st Louise Chen began coverage on ten large-cap biopharma companies an⁠d sh​ared‍ an “‍o‌ut-of-c⁠onsensus” positive view o‌n the‍ sector, according to a report by The Fly. She pointed out that years of underperfor‍manc‌e in […]",
    "url": "https://finnhub.io/api/news?id=efb00514119789443e001906bd0d6d0689e8613c795de94fdb8e7127b7f13960",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763262737,
      "headline": "Scotiabank Analyst Sees Opportunity in Large Cap Biopharma, Keeps Outperform on GILD",
      "id": 137494724,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) is included among the 15 Best Passive Income Stocks to Buy Right Now. On November 12, Scotiabank an⁠aly​st Louise Chen began coverage on ten large-cap biopharma companies an⁠d sh​ared‍ an “‍o‌ut-of-c⁠onsensus” positive view o‌n the‍ sector, according to a report by The Fly. She pointed out that years of underperfor‍manc‌e in […]",
      "url": "https://finnhub.io/api/news?id=efb00514119789443e001906bd0d6d0689e8613c795de94fdb8e7127b7f13960"
    }
  }
]